Multi-modality assessment of congestion in acute heart failure: Associations with left ventricular ejection fraction and prognosis

Alberto Palazzuoli,Gaetano Ruocco,Pierpaolo Pellicori,Luna Gargani,Stefano Coiro,Zohra Lamiral,Giuseppe Ambrosio,Tripti Rastogi,Nicolas Girerd
DOI: https://doi.org/10.1016/j.cpcardiol.2024.102374
IF: 16.464
2024-01-11
Current Problems in Cardiology
Abstract:Background Integrating clinical examination with ultrasound measures of congestion could improve risk stratification in patients hospitalized with acute heart failure (AHF). Aim To investigate the prevalence of clinical, echocardiographic and lung ultrasound (LUS) signs of congestion according to left ventricular ejection fraction (LVEF) and their association with prognosis in patients with AHF. Methods We pooled the data of four cohorts of patients ( N = 601, 74.9±10.8 years, 59 % men) with AHF and analysed six features of congestion at enrolment: clinical (peripheral oedema and respiratory rales), biochemical (BNP/NT-proBNP≥median), echocardiographic (inferior vena cava (IVC)≥21 mm, pulmonary artery systolic pressure (PASP)≥40 mmHg, E/e'≥15) and B-lines ≥25 (8-zones) in those with reduced (<40 %, HFrEF), mildly reduced (40–49 %, HFmrEF and preserved (≥50 %HFpEF) LVEF. Results Compared to patients with HFmrEF ( n = 110) and HFpEF ( n = 201), those with HFrEF ( N = 290) had higher natriuretic peptides, but prevalence of clinical (39 %), echocardiographic (IVC≥21 mm: 56 %, E/e'≥15: 57 %, PASP≥40 mmHg: 76 %) and LUS (48 %) signs of congestion was similar. In multivariable analysis, clinical (HR: 3.24(2.15–4.86), p < 0.001), echocardiographic [(IVC≥21 mm (HR:1.91, 1.21–3.03, p=0.006); E/e'≥15 (HR:1.54, 1.04–2.28, p = 0.031)] and LUS (HR:2.08, 1.34–3.24, p = 0.001) signs of congestion were significantly associated with all-cause mortality and/or HF re-hospitalization. Adding echocardiographic and LUS features of congestion to a model than included age, sex, systolic blood pressure, clinical congestion and natriuretic peptides, improved prediction at 90 and 180 days. Conclusions Clinical and ultrasound signs of congestion are highly prevalent in patients with AHF, regardless of LVEF and their combined assessment improves risk stratification.
cardiac & cardiovascular systems
What problem does this paper attempt to address?